feed,title,long_url,short_url
FDA:Recalls,"Azurity Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of ZenzediÂ® (dextroamphetamine sulfate tablets, USP) 30 mg Due to a Mislabeled Package During Manufacturing",http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/azurity-pharmaceuticals-inc-issues-voluntary-nationwide-recall-zenzedir-dextroamphetamine-sulfate,https://da.gd/jqXcH8
